Oddo BHF - BioNTech SE (BNTX) BioNTech SE : Une excellente visibilité financière, tous les regards sur BNT327

Report

Oddo BHF

Martial Descoutures

BioNTech SE : Une excellente visibilité financière, tous les regards sur BNT327

05/08/2025 1 FR

Underlying

BioNTech SE

See profile

US09075V1026 NASDAQ Stock Market Germany

Provider

Oddo BHF

Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

See profile

Analysts

Martial Descoutures

Other Reports on these Companies

Oddo BHF

BioNTech SE : Excellent financial visibility, all eyes on BNT327

43m 43m 1 EN

GlobeNewsWire

BioNTech veröffentlicht Ergebnisse für das zweite Quartal 2025 sowie Informationen zur Geschäftsentwicklung

BioNTech veröffentlicht Ergebnisse für das zweite Quartal 2025 sowie Informationen zur Geschäftsentwicklung BioNTech treibt Onkologiestrategie voran, u.a. mit zwei bekanntgegeben Transaktionen, und setzt damit den Fokus auf die zwei tumorübergreifenden (Pan-Tumor-)Programme: mRNA-Krebsimmuntherapie-Kandidaten und BNT327, ein gegen PD-L11 und VEGF-A gerichteter bispezifischer AntikörperkandidatAbschluss einer globalen strategischen Kollaborationsvereinbarung mit Bristol Myers Squibb („BMS“) zur gemeinsamen Durchführung eines umfangreichen klinischen Entwicklungsprogramms zur Evaluierung und ...

19h / 22m 19h / 22m 1 EN

SCOR : Good net income in Q2, with perception undermined by Covéa arbitration

1m 1m 1 EN

Patrick Steiner

Patrick Steiner

Lenzing : Q2 preview: Weaker fundamentals likely to offset operational progress

7m 7m 1 EN

Konrad Zomer

Konrad Zomer

Adecco : The best of the bunch

13m 13m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

BioNTech SE : Une excellente visibilité financière, tous les regards sur BNT327

BioNTech SE : Excellent financial visibility, all eyes on BNT327

BioNTech veröffentlicht Ergebnisse für das zweite Quartal 2025 sowie Informationen zur Geschäftsentwicklung

SCOR : Good net income in Q2, with perception undermined by Covéa arbitration

Lenzing : Q2 preview: Weaker fundamentals likely to offset operational progress

Adecco : The best of the bunch

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe